Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2022

Every FDA drug recall initiated in 2022, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,390 recalls, newest first.

Class II · Moderate risk

Neomycin Sulfate Tablets

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA Inc NDC 0093-1177-01 D-1473-2022
Class II · Moderate risk

Difluprednate Ophthalmic Emulsion

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Terminated Sterility / contamination Cipla NDC 69097-341-35 D-1499-2022
Class II · Moderate risk

Difluprednate Ophthalmic Emulsion

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Terminated Sterility / contamination Cipla NDC 76282-708-50 D-1498-2022
Class II · Moderate risk

Triamcinolone Acetonide Cream USP

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Terminated cGMP deviation Padagis US LLC NDC 45802-064-36 D-1497-2022
Class II · Moderate risk

Proton Armor

Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Terminated Chemical / undeclared Ultra Chem Labs Corp NDC 79208-001-50 D-0017-2023
Class II · Moderate risk

Proton Armor

Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Terminated Chemical / undeclared Ultra Chem Labs Corp NDC 79208-001-50 D-0016-2023

Recalls by year